Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Daniel Felmlee

Newcastle AuthorsTitleYearFull text
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Emeritus Professor Margaret Bassendine
Infection with the hepatitis C virus causes viral genotype-specific differences in cholesterol metabolism and hepatic steatosis2022
Emeritus Professor Margaret Bassendine
Dr Soren Nielsen
Dr Simon Bridge
Dr Daniel Felmlee
Dr David Sheridan
et al.		Hepatitis C virus and atherosclerosis: A legacy after virologic cure?2017
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Emeritus Professor Margaret Bassendine
Lipidomics analysis of fasting serum identifies novel lipid biomarkers specific for HCV genotype 3 and genotype 1 chronic hepatitis C virus infection2015
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Fiona Fenwick
Dr Clare Lanyon
et al.		PCSK9, apolipoprotein E and lipoviral particles in chronic hepatitis C genotype 3: Evidence for genotype-specific regulation of lipoprotein metabolism2015
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
Emeritus Professor Margaret Bassendine
Depressive symptoms in chronic hepatitis C are associated with plasma apolipoprotein E deficiency2014
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Fiona Fenwick
Dr R Neely
et al.		Omega-3 fatty acids and/or fluvastatin in hepatitis C prior non-responders to combination antiviral therapy - a pilot randomised clinical trial2014
Professor Margaret Bassendine
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Dr R Neely
Lipids and HCV2013
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Fiona Fenwick
Emeritus Professor Geoffrey Toms
et al.		Metabolic Syndrome and Insulin Resistance are Associated with Maximum Hepatitis C Lipoviral Particles in Genotype 1 Infection2013
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Fiona Fenwick
Professor Margaret Bassendine
Omega-3 Fatty Acids and/or Fluvastatin in Hepatitis C Prior Non-Responders to Combination Anti-Viral Therapy - A Pilot Randomised Clinical Trial2013
Dr David Sheridan
Dr Simon Bridge
Dr Daniel Felmlee
Emeritus Professor Geoffrey Toms
Dr R Neely
et al.		Apolipoprotein-E and hepatitis C lipoviral particles in genotype 1 infection: Evidence for an association with interferon sensitivity2012
Dr Simon Bridge
Dr David Sheridan
Dr Daniel Felmlee
Emeritus Professor Geoffrey Toms
Professor Margaret Bassendine
Apolipoprotein E and low-density, apolipoprotein B associated lipoviral particles in chronic Hepatitis C infection: Evidence for genotype-specific modulation of lipid pathways2011
Professor Margaret Bassendine
Dr David Sheridan
Dr Daniel Felmlee
Dr Simon Bridge
Emeritus Professor Geoffrey Toms
et al.		HCV and the hepatic lipid pathway as a potential treatment target2011
Dr Daniel Felmlee
Dr David Sheridan
Dr Simon Bridge
Emeritus Professor Geoffrey Toms
Professor Margaret Bassendine
Use of intralipid infusion to analyse apolipoprotein B (APOB) and HCV RNA kinetics in chronic infection2011
Dr David Sheridan
Professor Kim Bartlett
Dr Daniel Felmlee
Dr Simon Bridge
Emeritus Professor Geoffrey Toms
et al.		Hypocholesterolaemia in chronic hepatitis C genotype 3 infection is due to both reduced cholesterol production and increased LDL clearance2010
Dr David Sheridan
Professor Kim Bartlett
Dr Daniel Felmlee
Dr Simon Bridge
Emeritus Professor Geoffrey Toms
et al.		Hypocholesterolaemia in chronic Hepatitis C virus (HCV) infection - Reduced production or increased LDL clearance?2010
12